Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Wearable sensors could revolutionize how doctors assess stair climbing

NCT ID NCT06999850

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether wearable sensors can accurately measure how people climb stairs. Researchers will compare sensor data to traditional stopwatch timing in healthy volunteers and people with conditions like cerebral palsy, Parkinson's disease, and stroke. The goal is to see if this technology can provide more detailed information to help doctors assess movement problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide doctors with a more precise, objective way to assess stair-climbing ability in patients with conditions like cerebral palsy or Parkinson's disease.
What could go wrong
This is an early-stage observational study with only 64 participants. The test may not prove reliable or useful across different patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Common inclusion criteria for all groups: \- Ability to climb and descend 10 steps with supervision, even with handrail support. Common exclusion criteria for all groups: * Need for help from an operator or use of orthoses to make the stairs; * Inability to dress the instrumentation (accelerometer/electromyograph); * clinical condition that does not recommend the execution of scales (e.g. NYHA Class IV cardiovascular decompensation, epilepsy not controlled by drugs, serious visual disturbances...); * inability to follow verbal instructions. Inclusion criteria for the healthy group : * age 4-80 years (8 subjects 4-18 years; 8 subjects 19-65 years; 8 subjects 65-80 years); * absence of diagnosis of neurological or orthopaedic pathologies, which impair the patient's mobility. Inclusion criteria for the PCI group : * age range 4-18 years; * Diagnosis of Infantile Cerebral Palsy; * right or left hemiparesis; * ability motor skills in levels I - III according to the GMFCS (Gross Motor Function Classification System). Inclusion criteria for the Orthopaedic group: * Age 65-80 years; * postoperative postoperative hip or knee arthroplasty (in election and post-fracture, any revisions will be excluded). Inclusion criteria for the Amputee group: * age range from 19 to 80 years; * Leg amputation (trans-tibial), fitted with limb prosthesis. Inclusion criteria for the Parkinson's group: * age range from 65 years; * diagnosis of Parkinson's disease or Parkinsonism also on a vascular basis. Inclusion criteria for the group Ictus Cerebri: * Age 65-80 years; * Aftereffects of Ictus Cerebri; * left or right hemiparesis.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Instrumentation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ASP Istituti Milanesi Martinitt e Stelline e Pio Albergo Trivulzio

    RECRUITING

    Milan, Milano, 20146, Italy

  • IRCCS E. Medea

    RECRUITING

    Bosisio Parini, Lecco, 23842, Italy

  • IRCCS Istituti Clinici Maugeri Tradate

    RECRUITING

    Tradate, Varese, 21049, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.